HIV

Idaho Judge Paves Way for Controversial HIV Treatment Law Amidst Immigration Debate

by

A judge in Boise, Idaho, has issued a provisional decision regarding a state law that restricts access to HIV treatment for immigrants. This ruling could have significant implications for public health and the rights of individuals seeking medical care in the state. The law in question had previously come under scrutiny for potentially denying essential healthcare services to undocumented immigrants, particularly those living with HIV. Advocates argued that such restrictions could exacerbate health disparities and hinder efforts to control the spread of the virus. During a recent hearing, the judge reviewed arguments from both sides, … Read more

Idaho Doctor and Immigrant Patients Fight New Law Threatening Access to Critical HIV Medications

by

BOISE, Idaho — An Idaho doctor and four residents are taking legal action against a new state law that could significantly limit public health benefits for individuals living in the U.S. without legal authorization. This law threatens access to crucial HIV and AIDS medications for low-income patients, according to a federal lawsuit filed by the ACLU of Idaho. The lawsuit, submitted Thursday night, represents Dr. Abby Davids and four individuals with HIV, who remain unnamed due to their immigration status. The complaint argues that the legislation is ambiguous, conflicts with federal law, and complicates healthcare … Read more

Johnson & Johnson Subsidiary Fined $1.64 Billion Over Misleading HIV Drug Promotions

by

Philadelphia, PA – A U.S. jury has ruled against a Johnson & Johnson subsidiary, ordering the pharmaceutical giant to pay $1.64 billion in a landmark case that accuses the company of misleading marketing practices related to its HIV treatments. This verdict marks one of the largest in a series of legal challenges faced by the company. The case revolved around the allegations that Janssen Pharmaceuticals, a unit of Johnson & Johnson, engaged in false and misleading promotion of its drugs used to treat HIV. The lawsuit claimed that the company failed to adequately warn patients … Read more

Federal Court Orders Johnson & Johnson Unit to Pay $1.64 Billion in Landmark Whistleblower HIV Drug Case

by

Trenton, New Jersey – A federal judge has mandated Johnson & Johnson’s Janssen Pharmaceuticals unit to pay a hefty $1.64 billion for allegedly marketing two HIV medications, Prezista and Intelence, for unapproved uses. This order followed a recent jury verdict that found the company liable under whistleblower lawsuit claims. U.S. District Judge Zahid Quraishi ruled that Janssen violated the federal False Claims Act, leading to a direct $360 million fine. The company also faces civil fines amounting to $1.28 billion, which calculates to $8,000 for each of the 159,574 false claims submitted to government programs … Read more